Language:
繁简

Education Corner

RSV RSV Vaccine: Can Pregnant Women and Older Adults Get It?

Respiratory Syncytial Virus (RSV) is a common and highly contagious respiratory virus that can cause illnesses ranging from a mild cold to lower-respiratory-tract infections such as bronchiolitis and pneumonia. Infants and young children, older adults, and people with weakened immune systems face a higher risk of serious complications after infection.   In the early stage, RSV infection in babies often resembles a common cold and may include: Fever, runny nose, and nasal congestion Cough and throat discomfort Reduced appetite, low energy, or tiredness In some young children, middle-ear infection (otitis media)   If the virus affects the lower airways, a baby may develop rapid breathing, wheezing, breathing difficulty, feeding difficulty, or marked tiredness. In severe cases, it can progress to bronchiolitis or pneumonia; RSV is one of the important causes of bronchiolitis and pneumonia in infants under one year old. Seek medical care promptly or go to the emergency department if a baby has rapid breathing, chest indentation, blue or purple lips or face, difficulty feeding or drinking milk, unusual sleepiness, or a poor response.   How RSV spreads? RSV spreads mainly through: Respiratory droplets produced when an infected person coughs or sneezes Direct contact with secretions such as nasal mucus or saliva Touching contaminated toys, cots, tableware, or door handles and then touching the eyes, nose, or mouth The virus can survive for several hours on hard surfaces such as toys, cots, and tableware. Frequent handwashing and preventing people with respiratory symptoms from kissing or having close contact with babies can help reduce transmission.   Who can be infected? RSV can infect people of any age, but the risk and severity differ by group.   Group Common situation after infection Infants and young children More likely to develop lower-respiratory-tract infections such as bronchiolitis and pneumonia; severe cases may require hospitalisation Healthy adults Usually have only mild cold-like symptoms, but can still transmit the virus to babies or older adults Adults aged 60 or above Infection can cause serious lower-respiratory-tract disease and pneumonia, with a higher risk of hospitalisation People with chronic illnesses or weakened immunity More susceptible to more severe respiratory infections Even if a baby at home has not been infected, adults or older family members can be sources of transmission. While protecting babies, families should not overlook RSV risk among older adults. People at higher risk—particularly those with chronic lung disease, cardiovascular disease, diabetes, chronic kidney disease, or liver disease—should ask a doctor whether vaccination is appropriate. RSV vaccines: how are they given? Hong Kong currently has two registered RSV vaccines: AREXVY and ABRYSVO®, both given as a single dose. AREXVY is indicated for all adults aged 60 or above, as well as high-risk adults aged 50 to 59. High-risk groups include people with chronic conditions such as chronic obstructive pulmonary disease (COPD), asthma, cardiovascular disease, diabetes, chronic kidney disease, or liver disease. ABRYSVO® can be given during pregnancy at 32 to 36 weeks of gestation. Antibodies pass through the placenta to the fetus, providing protection against severe RSV lower-respiratory-tract disease during the baby’s first six months. Because RSV vaccines are not given directly to infants, maternal vaccination is the main way to provide vaccine-derived antibody protection to a baby before birth.   Who should consider vaccination? Suitable group Vaccination recommendation Pregnant women at 32 to 36 weeks of gestation May receive ABRYSVO® to protect babies from birth to 6 months old against severe RSV lower-respiratory-tract disease Adults aged 60 or above May receive a single-dose RSV vaccine—AREXVY or ABRYSVO®—to prevent RSV-related lower-respiratory-tract disease Adults aged 75 or above and residents of residential care homes The Hong Kong Centre for Health Protection committee considers individual vaccination an option after medical assessment and informed consent High-risk adults aged 18 to 59 Should consult a doctor first and decide based on individual health status and risk Every person’s situation differs. Doctors generally assess age, gestational age, chronic illnesses, allergy history, and individual risk before advising on vaccination.   Protection and effectiveness For pregnant women, RSV vaccination helps babies receive antibody protection after birth. Clinical-trial data show that maternal vaccination reduced the risk of severe RSV-related lower-respiratory-tract disease by about 81.8% within the first 90 days after birth, and by about 69.4% within 180 days. For adults aged 60 or above, RSV vaccines help prevent RSV-related lower-respiratory-tract disease. For example, real-world research during the 2023–24 season found that ABRYSVO® had approximately 79% effectiveness against RSV-related emergency-department visits and approximately 73% against related hospitalisation among adults aged 60 or above. Vaccine protection decreases over time; available data suggest protection of roughly 70% to 80% after two years.   Everyday prevention tips Q: If a baby gets RSV, will it definitely develop pneumonia? No. Most babies develop only mild cold-like symptoms such as a runny nose, cough, and fever, and can gradually recover with home care. However, some infants—especially premature babies, those under 6 months old, and those with congenital heart or lung disease or weakened immunity—are more likely to develop bronchiolitis or pneumonia. Seek immediate medical care if a baby has rapid breathing, wheezing, chest indentation, feeding difficulty, poor alertness, or blue lips.   Q: After a pregnant woman receives the RSV vaccine, will her baby never get RSV? No. The main purpose of maternal RSV vaccination is to transfer antibodies through the placenta and reduce the baby’s risk of severe RSV lower-respiratory-tract disease during the first six months after birth; it does not guarantee complete protection from infection. A baby can still be infected and have mild cold-like symptoms, but the risk of severe complications and hospitalisation can be substantially reduced.   Human Health offers several vaccination available on its online store, including: RSV respiratory syncytial virus vaccine (single Dose) (VACRSVGSK) $2,350 ABRYSVO® Respiratory Syncytial Virus Vaccine (Single Dose)

2026.11.16
RSV—BB Baby Has RSV: What Should Parents Watch For?

Babies have narrower airways and an immature immune system, so RSV infection can more easily lead to excess mucus, airway obstruction, and breathing difficulty. Although most cases are mild, babies under 6 months old, premature babies, and those with congenital heart or lung conditions or weakened immunity have a higher risk of developing bronchiolitis, pneumonia, or needing hospital admission.stacks.   Common changes after infection After a baby is infected with RSV, cold-like symptoms usually appear first. The virus may then affect the airways and lungs, making breathing more difficult. Parents should watch for the following changes: Runny nose or congestion, which can cause choking during feeding or slower feeding A cough that gradually worsens, or phlegm sounds and wheezing Faster breathing, flaring nostrils, or indentation between the chest and ribs while breathing Fever, reduced appetite, or decreased urine output Poor energy, unusual tiredness, difficulty being soothed, or excessive sleepiness   When to seek urgent care Do not simply wait and observe if your baby develops any of the following. Seek medical care immediately or go to the emergency department: Rapid breathing, obvious wheezing, or marked chest indentation while breathing Blue or purple lips, face, hands, or feet Difficulty feeding, a marked drop in milk intake, or signs of dehydration Repeated vomiting, seizures, unusual sleepiness, or a poor response Persistent fever, poor condition, or a clear change from their usual state   Home care essentials If your baby has mild symptoms, is feeding normally, and seems alert and well, parents can: Offer smaller, more frequent feeds rather than large feeds at once Keep indoor air well ventilated and avoid secondhand smoke Use saline to help clear nasal congestion and use a nasal aspirator as directed by healthcare professionals Monitor breathing, alertness, feeding amount, and how wet the nappies are Do not give adult cough medicines or antibiotics on your own; antibiotics do not help viral infections   How to lower infection risk Babies cannot directly receive the traditional RSV vaccine, so prevention mainly relies on reducing exposure: Wash hands before and after contact with the baby Anyone with cold or respiratory symptoms should avoid kissing the baby or providing close care Cover coughs and sneezes with a tissue, dispose of it immediately, and wash hands Regularly clean pacifiers, toys, cot rails, and surfaces the baby frequently touches Keep the home ventilated and prevent exposure to secondhand smoke   Can maternal vaccination protect the baby? Yes. When pregnant women receive a specific RSV vaccine between 32 and 36 weeks of pregnancy, antibodies can pass through the placenta to the fetus and provide protection against severe RSV lower-respiratory-tract disease during the baby’s first 6 months. This does not mean the baby will never get RSV, but it can substantially reduce the risk of severe infection and hospitalization.   Important reminder: If your baby has breathing difficulty, feeding difficulty, poor alertness, or a change in skin colour, do not wait too long to observe at home—seek medical care promptly.   Human Health offers several vaccination available on its online store, including: RSV respiratory syncytial virus vaccine (single Dose) (VACRSVGSK) $2,350 ABRYSVO® Respiratory Syncytial Virus Vaccine (Single Dose)

2026.11.16
未命名設計 (4) What are the differences between the various pneumococcal vaccines, and how should one choose?

Why Is "Serotype 3" Pneumococcus Important? In Hong Kong, Serotype 3 is a major pathogen threatening public health: Main Cause of Invasive Disease: Between 2016 and 2020, Serotype 3 caused 39%–49% of invasive pneumococcal disease (IPD) cases in adults and up to 59%–68% of cases in children locally. High-Risk Factor for Children: Nearly 70% of invasive diseases in infants and young children in Hong Kong are caused by Serotype 3. Comparison of New Conjugate Vaccines (15-valent / 20-valent / 21-valent) Comparison Item 15-valent Conjugate Vaccine (PCV15) 20-valent Conjugate Vaccine (PCV20) 21-valent Conjugate Vaccine (PCV21) Manufacturer Merck Pfizer Merck Suitable Age 6 weeks or older 6 weeks or older 18 years or older Dosage & Doses • 6 weeks to 7 months: 4 doses • 7 to 11 months: 3 doses • 1 to 2 years: 2 doses • 2 years or older: 1 dose • 6 weeks to 7 months: 4 doses • 7 to 11 months: 3 doses • 1 to 2 years: 2 doses • 2 years or older: 1 dose 1 dose only HK Registration Year 2022 April 2023 (Launched in 2021) 2026 Serotypes Covered 15 types 20 types 22 types Core Advantages • Immunogenicity against Serotype 3 is 60–77% higher than 13-valent and 20-valent vaccines • Adopted by the government since August 2024 to replace the 13-valent vaccine at Maternal and Child Health Centres (MCHCs) • Covers up to 83% of invasive serotypes, offering broader protection • Recommended by multiple countries including the US, Canada, Japan, and South Korea • Precisely targets the top three common serotypes in Hong Kong seniors (3, 15A, 23A) • Covers over 70% of invasive serotypes, aligning with the latest WHO recommendations Vaccine Types & Scope of Protection Conjugate Vaccines (PCV13 / PCV15 / PCV20): Stimulate long-term immune memory. Effectively cover the highly invasive Serotype 3, as well as the highly antibiotic-resistant Serotypes 6A and 19A. Polysaccharide Vaccine (PPV23): Covers 23 serotypes, but does not include Serotype 6A, and its immune memory is weaker than that of conjugate vaccines. Infant & Toddler Vaccination Schedule (15-valent / 20-valent) Starting Age Recommended Total Doses Vaccination Schedule 6 weeks and older 4 doses* Administered at 2 months, 4 months, 6 months, and 12–15 months of age 7 months and older 3 doses Completed within approximately 6 months 1 – 2 years old 2 doses Administered at least 2 months apart Over 2 years old 1 dose 1 dose only *Since July 2019, the Department of Health in Hong Kong changed the free pneumococcal vaccination schedule for children born in or after 2019 from 4 doses to 3 doses (removing the 3rd dose at 6 months of age). Parents may choose to have their baby receive a self-paid booster dose at 6 months of age as needed. Additional Protection: Children over 2 years old who have completed the 15-valent vaccination may consider receiving 1 dose of the 20-valent vaccine to broaden their protection. Adult & Elderly Vaccination Arrangements 13-valent / 15-valent Conjugate Vaccine (2 years or older): Only 1 dose is required. 20-valent Conjugate Vaccine (18 years or older): Only 1 dose is required. 23-valent Polysaccharide Vaccine: After receiving 1 dose, a 2nd dose may be required after 5 years subject to a doctor's assessment.   Interested in the pneumococcal vaccine? Click the link below to purchase it directly from our online store, or contact us for more information. Pneumococcal Vaccine – Human Health Eshop

2026.11.13
糖尿病生蛇 Are People with Diabetes More Likely to Develop Shingles? Understanding the Risks and Prevention Through a Case Study

Appointments and Service Details   World Diabetes Day falls on 14 November each year. In addition to managing blood glucose levels, people with diabetes should be aware of other related health risks, including shingles, also known as herpes zoster.   What Is Shingles, and Why Does the Virus Reactivate?   Shingles, medically known as herpes zoster, is caused by the varicella-zoster virus. After a person recovers from chickenpox, the virus can remain dormant in the nervous system. If immune function declines, the virus may reactivate and cause shingles. According to the report, ageing, excessive fatigue and illness may be associated with viral reactivation. Shingles does not affect older adults alone; younger adults and students can also develop the condition. Being young or generally feeling well should therefore not be a reason to overlook the risk.   How Do Diabetes and Shingles Affect Each Other?   The report cited research suggesting that people with diabetes have an approximately 40% higher relative risk of developing shingles than the general population. This describes a difference in relative risk between two groups; it does not mean that 40 out of every 100 people with diabetes will develop shingles. In addition to a higher risk of developing shingles, people with diabetes are more likely to experience postherpetic neuralgia—persistent nerve pain following shingles. Even after the skin symptoms have improved, the pain may continue, affecting daily activities and quality of life. The relationship between diabetes and shingles is not one-way. According to the report, shingles may make blood glucose levels more difficult to control and may worsen other existing conditions, with some patients requiring hospital treatment. During an episode of shingles, it is therefore important to monitor existing health conditions as well as manage the skin symptoms and pain.   Having Had Shingles Does Not Rule Out Recurrence   The report quoted a doctor as reminding readers that people with diabetes may have weaker immune function and a higher risk of shingles recurrence. Having had shingles before should therefore not be taken to mean that preventive measures are no longer necessary. The pain associated with early shingles may be difficult to recognise. In the case described above, the man was only diagnosed after blisters appeared on his scalp. Anyone who develops symptoms suggestive of shingles, such as an unusual rash, blisters, pain or fever, should seek medical attention promptly rather than self-diagnosing or delaying treatment. The report noted that appropriate antiviral treatment within 72 hours of symptom onset can help shorten the period during which blisters develop and reduce pain. Even if symptoms have already persisted for some time, patients should still seek medical advice so that a doctor can assess their treatment and follow-up needs.   What Steps Can Be Taken for Prevention and Management? Check and Manage Blood Pressure, Cholesterol and Blood Glucose as Appropriate   The report cited a doctor’s recommendation to pay attention to the screening and management of high blood pressure, high blood lipids and high blood glucose. After recovering from shingles, patients may also discuss with their doctor whether checks for these conditions, along with liver and kidney function tests, are appropriate to identify any underlying health problems. The choice and timing of tests should be based on individual circumstances.   Monitor Existing Health Conditions During Infection   People with diagnosed diabetes who develop shingles or experience other changes in their health should inform their treating doctor. This allows the doctor to assess whether their blood glucose control or other existing conditions require further follow-up.   Explore Shingles Prevention Options   Healthy lifestyle habits help support immune function, but they may not completely prevent shingles. People with diabetes can ask a healthcare professional about their individual shingles risk and available preventive options, including vaccination. Understanding the benefits, limitations and potential side effects can help them make an informed decision.   Look Beyond Blood Glucose to Related Health Risks   World Diabetes Day is not only a reminder to monitor blood glucose levels, but also an opportunity to review overall health. Appropriate testing, ongoing management and early discussions about prevention can help provide a clearer direction for personal healthcare.   Appointments and Service Details

2026.11.13
未命名設計 (3) What are "bone-building injections," and who should consider using them?

For general osteoporosis patients, bone loss can be improved through "antiresorptive injections" (Prolia / Denosumab) combined with nutritional supplements and moderate exercise. However, for individuals with severe osteoporosis or those at extremely high risk of fracture, doctors may recommend "bone-building injections" (anabolic agents) as the preferred first-line treatment. What is the difference between "Antiresorptive Injections" and "Bone-Building Injections"? Antiresorptive Injections: Primarily inhibit osteoclasts, slowing down the rate of bone loss and resorption. Bone-Building Injections: Primarily stimulate the body to produce new bone tissue, improving overall bone quality. New-Generation Bone-Building Injections: Offer a dual action of both "bone-building" and "anti-resorption," helping to enhance bone strength and reduce the risk of future recurrent fractures. Who is at extremely high risk of fracture? If you meet any of the following criteria, it is recommended to seek an evaluation early and discuss with a doctor whether "bone-building injections" are suitable for you: -Fractures occurred within the past 24 months; or -History of multiple fractures; or -Extremely low bone mineral density (T-score ≤ -3.0); or -Evaluated by a doctor as being at extremely high risk of fracture. For individuals who have recently suffered a fracture or have experienced multiple fractures, early evaluation and appropriate treatment are particularly crucial. Doctors will evaluate and determine the most suitable treatment plan based on a combination of factors, including bone density reports, fracture history, age, kidney function, and overall health status. You can also better understand your bone health through a DEXA bone mineral density scan. Checkup Details: https://mall.humanhealth.com.hk/products/dexa

2026.10.29
未命名設計 (1) Osteoporosis doesn’t just increase the risk of fractures—could its impact actually last a lifetime?

According to data*, after experiencing a fracture, the risk of a secondary fracture can increase by up to 10 times, with the risk being highest in the first two years following the initial fracture. In severe cases such as hip fractures, the one-year mortality rate can reach as high as 17.3%. Even if less severe, it may still lead to functional problems such as joint stiffness, limited mobility, or muscle atrophy, impacting daily life. Preventing fractures starts with addressing osteoporosis. Are you or elderly family members high-risk individuals for fractures? - Aged 65 or above without regular bone mineral density (BMD) check-ups - Low bone mineral density (e.g., T-score ≤ −2.5) - History of multiple falls Many people mistakenly assume that osteoporosis is simply a natural part of aging and impossible to improve once it occurs. In fact, osteoporosis can be improved through appropriate medical treatment and ongoing management—the key is early detection. Can osteoporosis be reversed? In medical terms, osteoporosis can be "reversed." Of course, this reversal does not mean returning to the bone state of one's youth, but rather progressing from a "high-risk zone" to a "safe zone." Through continuous and correct pharmacological treatment, nutritional supplementation, and exercise, a patient's bone density and muscle mass can improve significantly, and bone structure can be restored, thereby drastically reducing the risk of future fractures. Why are you more prone to a second fracture after having one? The medical community refers to this phenomenon as the "fracture cascade effect" or "domino effect," driven mainly by the following reasons: The root cause, "osteoporosis," remains unaddressed: Many initial fractures stem from minor falls, light bumps, or even everyday actions like sneezing (fragility fractures). If only the broken bone is treated without tackling the underlying osteoporosis, the chance of refracture remains high. Fractures trigger cascading collapses: Taking vertebral fractures as an example, when one vertebra collapses, the weight-bearing balance of the spine is disrupted. The body's center of gravity shifts forward, placing greater pressure on adjacent vertebrae and increasing the risk of cascading collapse. Post-fracture condition easily triggers a vicious cycle: Due to pain or fear of re-injury, physical activity is reduced after a fracture. This can lead to muscle loss, joint stiffness, and impaired balance, which significantly increases the likelihood of falling again—creating a vicious cycle. This is why regular check-ups are strongly recommended, as early detection and early prevention are vital. The pain of a fracture can potentially persist for a lifetime, and prevention is always better than cure. If you or someone close to you belongs to a high-risk group, it is advisable to learn more about preventive measures early and undergo regular DEXA bone density scans:https://mall.humanhealth.com.hk/products/dexa *Reference source: The Osteoporosis Society of Hong Kong

2026.10.29